Pancreatitis concerns take shine off Victoza approval
January 28, 2010Sales and Marketing GLP-1, Novo Nordisk, Victoza
The FDA has approved Novo Nordisk’s Victoza a new once-daily injection for patients with type II diabetes. The drug will …
Cell Medica bolsters senior management
January 28, 2010Research and Development Cell Medica, appointment, research and development
London-based cellular therapeutics company Cell Medica has made four key appointments. Dr Rainer Knaus joins the company as senior vice …
Orencia wins expanded European licence
January 27, 2010Sales and Marketing BMS, Orencia, rheumatoid arthritis
BMS’s Orencia has been approved in Europe to treat children aged six and over who suffer from a form of …
BBC highlights AZ’s Seroquel woes
January 27, 2010Sales and Marketing AstraZeneca, Seroquel, industry reputation
AstraZeneca’s ongoing US legal battle over its antipsychotic drug Seroquel was highlighted this week in a BBC radio programme. AstraZeneca …
UK’s research ‘Super Cluster’ unveiled
January 27, 2010Research and Development, Sales and Marketing ABPI, clinical research, innovation, patent box
GlaxoSmithKline chief executive Andrew Witty has hailed a new UK government ‘blueprint’ to help improve the country’s competitiveness in the …
Romaco and Ankur target oral film strip market
January 27, 2010Manufacturing and Production, Research and Development, Sales and Marketing Ankur, Romaco, drug delivery, film strips
Packaging and processing technology specialist Romaco has kitted out Indian drugmaker Ankur Drugs and Pharma with a production line for …
BioCeramic Therapeutics appoints Ian Brown
January 27, 2010Research and Development BioCeramic Therapeutics, appointment, research and development
BioCeramic Therapeutics has appointed Ian Brown chief executive, taking over from Daniel Green who will remain on the board as …
In brief: European Medicines Agency news
January 26, 2010Research and Development, Sales and Marketing Arepanrix, Arzerra, EMEA, GSK, Tysabri
GlaxoSmithKline’s influenza vaccine Arepanrix has been granted conditional marketing authorisation in Europe under an emergency fast-track procedure.It is the fourth …
Quintiles re-positions itself for changing biopharma industry
January 26, 2010Research and Development, Sales and Marketing CRO, Quintiles
Leading services company Quintiles has unveiled a new corporate identity to help showcase the diversity of its business.The company, best …
Digital Pharma – Online patient recruitment drive for GSK’s anxiety drug
January 26, 2010Research and Development GlaxoSmithKline, PTSD, digital research, orvepitant, patient recruitment
GlaxoSmithKline is readying to move its post-traumatics stress disorder candidate orvepitant into phase II trials, a move being supported by …
New ways of measuring sales performance needed
January 26, 2010Business Services, Sales and Marketing sales force effectiveness, training
Research funded by the Chartered Institue of Management Accountants (CIMA) has helped Cranfield School of Management unveil a new framework …
Huge drug discovery database launched
January 26, 2010Research and Development ChEMBLdb, Wellcome, genome, genomics
A huge online database of information on the properties and activities of drugs and drug-like small molecules and their targets …
Merck appoints UK leadership team
January 26, 2010MSD, Merck & Co, appointment
Merck & Co’s UK business has unveiled its new leadership team, following last year’s merger with Schering-Plough. Merck Sharp & …
National clinical directors appointed
January 26, 2010NHS, UK, appointment, dementia, elderly, liver disease
A trio of national clinical directors, whose areas of influence cover dementia, older people and liver disease, have been appointed …
Roche invests in production of new Herceptin formulation
January 25, 2010Manufacturing and Production, Research and Development Herceptin, Roche
Roche will spend 190 million Swiss francs ($183m) to put production capacity in place for a new self-administered formulation of …
Niche pharma company HRA expands into Spain
January 25, 2010Sales and Marketing HRA Pharma, Spain
French reproductive health and endocrinology company HRA Pharma has set up commercial operations in Spain, its fifth European base to …
PPD lists market recovery and more acquisitions in 2010 forecasts
January 25, 2010Research and Development CRO, Caprion Proteomics, PPD
Pharmaceutical Product Development (PPD) expects revenues in 2010 to grow around 6% as the high rate of project cancellations in …
Manufacturing news in brief
January 25, 2010Manufacturing and Production Elona Biotech, Genzyme, Lupin, Patheon, State Pharmaceuticals Manufacturing, SurModics
Our round-up of developments in pharmaceutical manufacturing includes a new contract between Patheon and Sanofi-Aventis, hiring plans at Genzyme and …
Abbott’s weight-loss drug suspended in Europe
January 25, 2010Sales and Marketing Abbott, Reductil
Doctors have been told not to prescribe Abbott’s weight-loss treatment sibutramine after a safety review found evidence of serious cardiovascular …
Clavis Pharma appoints Olav Hellebø
January 25, 2010Research and Development, Sales and Marketing Clavis Pharma, appointment, research and development, sales and marketing
Norwegian cancer drug development company Clavis Pharma has appointed Olav Hellebø as its new chief executive. He joins the company …
Latest content
Scots neonatal innovations target hearing loss and earlier care
Agentis Health Group acquires Clinical Pharmacist Solutions
